Search Results

Dasatinib 500 mg  | 99.89%

TargetMol

Dasatinib is a potent inhibitor of the Bcr-Abl and Src family (IC50s: 0.6, 0.8, 79 and 37 nM for Abl, Src, c-Kit, and c-KitD816V, respectively).

More Information Supplier Page

Dasatinib 200 mg  | 99.89%

TargetMol

Dasatinib is a potent inhibitor of the Bcr-Abl and Src family (IC50s: 0.6, 0.8, 79 and 37 nM for Abl, Src, c-Kit, and c-KitD816V, respectively).

More Information Supplier Page

Palbociclib Isethionate 200 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Palbociclib Isethionate 100 mg  | Purity Not Available

TargetMol

Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.

More Information Supplier Page

Telmisartan 100 mg  | 98.78%

TargetMol

Telmisartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of telmisartan is as an Angiotensin 2 Receptor Antagonist.

More Information Supplier Page

Telmisartan 50 mg  | 98.78%

TargetMol

Telmisartan is an Angiotensin 2 Receptor Blocker. The mechanism of action of telmisartan is as an Angiotensin 2 Receptor Antagonist.

More Information Supplier Page

Forskolin 10 mg  | 98.83%

TargetMol

Forskolin, a potent activator of the adenylate cyclase (EC50: 0.5 μM), can increase the cAMP level. It is extracted from the plant Coleus forskohlii.

More Information Supplier Page

Dolasetron Mesylate hydrate 50 mg  | 99.86%

TargetMol

Dolasetron mesylate, a selective serotonin receptor antagonist, competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.

More Information Supplier Page